February 27, 2018
Via: ForbesThe firm, Quentis Therapeutics, says that the money will fund clinical trials for its new medicine, a small molecule IRE1α inhibitor, to begin next year. The idea is that harsh conditions within tumors inhibit the immune system from attacking the […]
March 28, 2024
April 19, 2024